Ghent University Academic Bibliography

Journal Article
A1
open access

A human-like glutaminase-free asparaginase is highly efficacious in ASNS-low leukemia and solid cancer mouse xenograft models

Maaike Van Trimpont (UGent) , Amanda M. Schalk, Kenneth Hofkens (UGent) , Evelien Peeters (UGent) , Sara T'Sas (UGent) , Katrien Vandemeulebroecke (UGent) , Ying Su, Ashley De Loera, Alyssa Garcia, Hui Chen, et al.

(2025) CANCER LETTERS. 611.

Add to list

Journal Article
A1
open access

System Xc(-) inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance

Fang Wang, Inge Oudaert, Chenggong Tu, Anke Maes, Arne Van Der Vreken, Philip Vlummens (UGent) , Elke De Bruyne, Kim De Veirman, Yanmeng Wang, Rong Fan, et al.

(2022) CANCER LETTERS. 535.

Add to list

Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway

Kim De Veirman, Eline Menu, Ken Maes, Nathan De Beule, Eva De Smedt, Anke Maes, Philip Vlummens (UGent) , Karel Fostier, Alboukadel Kassambara, Jerome Moreaux, et al.

(2019) CANCER LETTERS. 442. p.233-241

Add to list

Integrated transcriptomic and epigenomic analysis of ovarian cancer reveals epigenetically silenced GULP1

Leonel Maldonado, Mariana Brait, Evgeny Izumchenko, Shahnaz Begum, Aditi Chatterjee, Tanusree Sen, Myriam Loyo, Alvaro Barbosa, Maria Luana Poeta, Eugene Makarev, et al.

(2018) CANCER LETTERS. 433. p.242-251

Add to list

Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2-associated hereditary breast and ovarian cancer reveals multiple co-acting second hits

Mattias Van Heetvelde (UGent) , Mieke Van Bockstal (UGent) , Bruce Poppe (UGent) , Kathleen Lambein, Toon Rosseel (UGent) , Lilit Atanesyan, Dieter Deforce (UGent) , Ivo Van Den Berghe, Kim De Leeneer (UGent) , Jo Van Dorpe (UGent) , et al.

(2018) CANCER LETTERS. 425. p.125-133

Add to list

Immunological, anti-angiogenic and clinical effects of intratumoral interleukin 12 electrogene therapy combined with metronomic cyclophosphamide in dogs with spontaneous cancer : a pilot study

Laetitia Cicchelero (UGent) , Sofie Denies (UGent) , Katrien Vanderperren (UGent) , Emmelie Stock (UGent) , Leen Van Brantegem (UGent) , Hilde De Rooster (UGent) and Niek Sanders (UGent)

(2017) CANCER LETTERS. 400. p.205-218

Add to list

Next generation sequencing of microRNAs from isogenic neuroblastoma cell lines isolated before and after treatment

Sarah Andrea Roth, Erik Knutsen, Tonje Fiskaa, Peter Utnes, Swapnil Bhavsar, Øyvind H Hald, Cecilie Løkke, Pieter Mestdagh (UGent) , Steinar D Johansen, Trond Flægstad, et al.

(2016) CANCER LETTERS. 372(1). p.128-136

Add to list

MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma

Anneleen Beckers (UGent) , Gert Van Peer (UGent) , Daniel R Carter, Moritz Gartlgruber, Carl Herrmann, Saurabh Agarwal, Hetty Helsmoortel (UGent) , Kristina Althoff, Jan J Molenaar, Belamy B Cheung, et al.

(2015) CANCER LETTERS. 366(1). p.123-132

Add to list

Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer

Tom Van Maerken (UGent) , Ali Rihani (UGent) , Alan Van Goethem (UGent) , Anne De Paepe (UGent) , Franki Speleman (UGent) and Jo Vandesompele (UGent)

(2014) CANCER LETTERS. 344(2). p.157-165

Add to list

Journal Article
A1
open access

A personalized view on cancer immunotherapy

Laura Wayteck (UGent) , Karine Breckpot, Jo Demeester (UGent) , Stefaan De Smedt (UGent) and Koen Raemdonck (UGent)

(2014) CANCER LETTERS. 352(1). p.113-125

Academic Bibliography

A human-like glutaminase-free asparaginase is highly efficacious in ASNS-low leukemia and solid cancer mouse xenograft models

System Xc(-) inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance

Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway

Integrated transcriptomic and epigenomic analysis of ovarian cancer reveals epigenetically silenced GULP1

Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2-associated hereditary breast and ovarian cancer reveals multiple co-acting second hits

Immunological, anti-angiogenic and clinical effects of intratumoral interleukin 12 electrogene therapy combined with metronomic cyclophosphamide in dogs with spontaneous cancer : a pilot study

Next generation sequencing of microRNAs from isogenic neuroblastoma cell lines isolated before and after treatment

MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma

Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer

A personalized view on cancer immunotherapy

Contents

Support

Contact